Similar articles

• [Evaluation of the effectiveness of isoprinosine in the treatment of patients with acute viral hepatitis. I. Clinical evaluation].

  Michalska Z, Dubicka M, Nedoszytko B, Gajda A. Michalska Z, et al. Wiad Lek. 1987 Oct 15;40(20):1369-74. Wiad Lek. 1987. PMID: 2451357 Clinical Trial. Polish. No abstract available.
• [Evaluation of the effectiveness of isoprinosine in the treatment of patients with acute viral hepatitis. II. Immunological evaluation].

  Nedoszytko B, Michalska Z, Dubicka M, Gajda A. Nedoszytko B, et al. Wiad Lek. 1987 Nov 1;40(21):1469-74. Wiad Lek. 1987. PMID: 2453975 Clinical Trial. Polish. No abstract available.
• [Treatment of chronic active hepatitis (HBsAg +,HBeAg +) with isoprinosine. Clinical evaluation].

  Cianciara J, Loch T, Babiuch L, Dabrowska-Bernstein B, Stasiak A, Dabrowski M, Pawińska A. Cianciara J, et al. Pol Tyg Lek. 1988 Sep 12;43(37):1195-8. Pol Tyg Lek. 1988. PMID: 2470069 Clinical Trial. Polish. No abstract available.
• [Isoprinosine--a drug with antiviral and immunomodulating action].

  Deroń Z. Deroń Z. Wiad Lek. 1984 Sep 1;37(17):1355-61. Wiad Lek. 1984. PMID: 6084363 Review. Polish. No abstract available.
• Inosiplex: an immunomodulation model for the treatment of viral disease.

  Ginsberg T, Glasky AJ. Ginsberg T, et al. Ann N Y Acad Sci. 1977 Mar 4;284:128-38. doi: 10.1111/j.1749-6632.1977.tb21944.x. Ann N Y Acad Sci. 1977. PMID: 81634 Review. No abstract available.